Cargando…
Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome
The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Mül...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546405/ https://www.ncbi.nlm.nih.gov/pubmed/23326012 |
_version_ | 1782256049880825856 |
---|---|
author | FUSETTI, M. FIORETTI, A.B. VALENTI, M. MASEDU, F. LAURIELLO, M. PAGLIARELLA, M. |
author_facet | FUSETTI, M. FIORETTI, A.B. VALENTI, M. MASEDU, F. LAURIELLO, M. PAGLIARELLA, M. |
author_sort | FUSETTI, M. |
collection | PubMed |
description | The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Müller's manoeuvre, overnight cardio-respiratory monitoring, Epworth Sleepiness Scale (ESS) to measure daytime sleepiness, body mass index (BMI), measurement of blood pressure and blood tests. Subsequently, subjects were divided into three subgroups according to the Apnoea Hypopnoea Index (AHI): mild OSAS (AHI 5-15), moderate OSAS (AHI 15-30) and severe OSAS (AHI > 30). In the sample collected, 347 (262 males and 85 females) of 1185 patients suffered from mild OSAS, 363 (269 males and 94 females) from moderate OSAS and 475 (330 males and 145 females) from severe OSAS. In the group suffering from mild OSAS, we found: 127 patients affected by hypertension, 48 with diabetes, 11 with dyslipidaemia and 32 with metabolic syndrome. In the group with moderate OSAS there were 157 patients with hypertension, 63 with diabetes, 72 with dyslipidaemia and 47 with metabolic syndrome. In the group suffering from severe OSAS there were 244 patients with hypertension, 138 with diabetes, 47 with dyslipidaemia and 90 with metabolic syndrome. For data analysis, we used the Spearman correlation test adjusted according to Sidak between the dependent variable AHI and the independent variables BMI, ESS, average SO2 (SO(2med)), hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. The results show different patterns of correlation in terms of statistical significance: BMI ρ(s) = 0.26, SO(2med) ρ(s) = -0:51, hypertension ρ(s) = -0.05, dyslipidaemia ρ(s) = 0.22 for women, and BMI ρ(s) = 0.53, ESS ρ(s) = 0.28, SO(2med) ρ(s) = -0.50, hypertension ρ(s) = 0.17, diabetes mellitus ρ(s) = 0.28 and metabolic syndrome ρ(s) = 0.26 for men. The results of the study confirm the existence of a statistically significant correlation between the severity of OSAS and BMI, ESS, average SO2, hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. |
format | Online Article Text |
id | pubmed-3546405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Pacini Editore SpA |
record_format | MEDLINE/PubMed |
spelling | pubmed-35464052013-01-16 Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome FUSETTI, M. FIORETTI, A.B. VALENTI, M. MASEDU, F. LAURIELLO, M. PAGLIARELLA, M. Acta Otorhinolaryngol Ital Sleep Medicine The purpose of this study was to evaluate the correlation between severity of obstructive sleep apnoea syndrome (OSAS), cardiovascular disease and metabolic syndrome. We recruited 1185 patients with OSAS who underwent a complete ENT examination, including nasolaryngeal fibre optic endoscopy with Müller's manoeuvre, overnight cardio-respiratory monitoring, Epworth Sleepiness Scale (ESS) to measure daytime sleepiness, body mass index (BMI), measurement of blood pressure and blood tests. Subsequently, subjects were divided into three subgroups according to the Apnoea Hypopnoea Index (AHI): mild OSAS (AHI 5-15), moderate OSAS (AHI 15-30) and severe OSAS (AHI > 30). In the sample collected, 347 (262 males and 85 females) of 1185 patients suffered from mild OSAS, 363 (269 males and 94 females) from moderate OSAS and 475 (330 males and 145 females) from severe OSAS. In the group suffering from mild OSAS, we found: 127 patients affected by hypertension, 48 with diabetes, 11 with dyslipidaemia and 32 with metabolic syndrome. In the group with moderate OSAS there were 157 patients with hypertension, 63 with diabetes, 72 with dyslipidaemia and 47 with metabolic syndrome. In the group suffering from severe OSAS there were 244 patients with hypertension, 138 with diabetes, 47 with dyslipidaemia and 90 with metabolic syndrome. For data analysis, we used the Spearman correlation test adjusted according to Sidak between the dependent variable AHI and the independent variables BMI, ESS, average SO2 (SO(2med)), hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. The results show different patterns of correlation in terms of statistical significance: BMI ρ(s) = 0.26, SO(2med) ρ(s) = -0:51, hypertension ρ(s) = -0.05, dyslipidaemia ρ(s) = 0.22 for women, and BMI ρ(s) = 0.53, ESS ρ(s) = 0.28, SO(2med) ρ(s) = -0.50, hypertension ρ(s) = 0.17, diabetes mellitus ρ(s) = 0.28 and metabolic syndrome ρ(s) = 0.26 for men. The results of the study confirm the existence of a statistically significant correlation between the severity of OSAS and BMI, ESS, average SO2, hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome. Pacini Editore SpA 2012-10 /pmc/articles/PMC3546405/ /pubmed/23326012 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/ |
spellingShingle | Sleep Medicine FUSETTI, M. FIORETTI, A.B. VALENTI, M. MASEDU, F. LAURIELLO, M. PAGLIARELLA, M. Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title_full | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title_fullStr | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title_full_unstemmed | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title_short | Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
title_sort | cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome |
topic | Sleep Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546405/ https://www.ncbi.nlm.nih.gov/pubmed/23326012 |
work_keys_str_mv | AT fusettim cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome AT fiorettiab cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome AT valentim cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome AT maseduf cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome AT lauriellom cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome AT pagliarellam cardiovascularandmetaboliccomorbiditiesinpatientswithobstructivesleepapnoeasyndrome |